Retinal Detachment Treatment — Cost, Top Hospitals & Success Rates | MyMedicPlus

Retinal detachment (RD) is a sight-threatening condition in which the neurosensory retina separates from the underlying retinal pigment epithelium (RPE) and choroid, interrupting the essential metabolic exchange between these layers. Without prompt surgical intervention, photoreceptors deprived of their blood supply undergo irreversible degeneration, leading to permanent visual loss.

The annual incidence of rhegmatogenous retinal detachment (RRD) — the most common type — is approximately 10–15 per 100,000 population. Risk is substantially elevated in high myopes (axial length >26 mm), post-cataract surgery patients, and individuals with a history of significant blunt ocular trauma or lattice degeneration.

Recognising retinal detachment symptoms is critical for timely intervention:

• New onset or sudden increase in floaters (particularly a shower of small black dots)
• Photopsia — flashes of light in peripheral vision (caused by vitreous traction on the retina)
• A curtain or shadow spreading across the visual field, indicating extension of the detachment toward the macula
• Sudden, painless central vision loss if the macula has detached

The distinction between macula-on (fovea still attached) and macula-off (fovea detached) RD is the most clinically critical determination, as it dictates surgical urgency. Macula-on RD is a true ophthalmic emergency requiring surgery within hours to a day to preserve central vision.

Retinal detachment is classified by mechanism and requires different surgical approaches accordingly:

• Rhegmatogenous Retinal Detachment (RRD): The most common type (~85%). Caused by a full-thickness retinal break (tear or hole) through which liquefied vitreous passes, accumulating beneath the retina and separating it from the RPE. Horseshoe tears from posterior vitreous detachment (PVD), atrophic holes in lattice degeneration, and dialyses (in young patients after blunt trauma) are common causes.
• Tractional Retinal Detachment (TRD): Caused by fibrovascular proliferative membranes pulling the retina forward. Most commonly seen in proliferative diabetic retinopathy (PDR), sickle cell retinopathy, and retinopathy of prematurity. Treatment is primarily pars plana vitrectomy (PPV) with membrane dissection; scleral buckling alone is insufficient.
• Exudative (Serous) Retinal Detachment: Subretinal fluid accumulates without a retinal break, driven by inflammatory, vascular, or neoplastic pathology (uveitis, malignant hypertension, choroidal tumours, Vogt-Koyanagi-Harada disease). Treatment targets the underlying cause rather than surgery on the retina.
• Giant Retinal Tears (GRT): Retinal breaks extending ≥90° of circumference; require PPV with perfluorocarbon liquid (PFCL) unfolding and silicone oil tamponade.
• Proliferative Vitreoretinopathy (PVR): The formation of contractile membranes on the retinal surface following RRD or as a complication of RD surgery; the most common cause of surgical failure and re-detachment.

All rhegmatogenous and tractional retinal detachments require surgical treatment. Urgency is stratified by macula status and disease extent:

Macula-On RRD — Ophthalmic Emergency:

• If the macula remains attached, surgery is ideally performed the same day or within 24 hours to prevent macular involvement. Each hour of delay increases the risk of macula-off conversion.
• Avoidance of prone or supine positioning, reduced physical activity, and immediate referral to a vitreoretinal unit are required.

Macula-Off RRD — Urgent but not same-day:

• If the macula has already detached, surgery within 3–7 days (preferably <7 days of macular detachment) is associated with better visual outcomes than very delayed repair. Beyond 7–14 days, photoreceptor viability progressively decreases.
• OCT of the macula helps assess outer retinal layer integrity (IS/OS band) and predict post-operative visual prognosis.

Treatment selection factors:

• Lens status (phakic vs. pseudophakic/aphakic) — critical for PIVOT trial evidence
• Break location, size, and number
• Presence of PVR (grade C or D may require vitrectomy with silicone oil)
• Degree of vitreous liquefaction (syneresis)
• Fellow eye and patient anaesthetic fitness

Three primary surgical strategies exist for RRD repair, each with specific indications:

1. Pneumatic Retinopexy (PR)

• An office-based procedure involving injection of an expansile gas bubble (usually sulphur hexafluoride, SF6) into the vitreous cavity, followed by cryotherapy or indirect laser retinopexy to seal the break.
• Best suited for superior retinal breaks (between 8 and 4 o'clock), minimal PVR, and a single or cluster of breaks within 1 clock hour.
• Primary anatomical success rate of approximately 75–80% for appropriately selected cases; re-treatment rates are higher than PPV but the procedure avoids operating room costs and risks.
• Requires strict post-operative face-up or tilted head positioning for 1–3 days to maintain the gas bubble over the break.

2. Scleral Buckling (SB)

• Involves placement of a silicone sponge or solid band (Lincoff sponge) sutured to the sclera to indent the eye wall, relieving vitreous traction and closing the retinal break.
• Segmental buckling targets the break directly; encircling buckles (360° band) support multiple breaks or when break localisation is uncertain.
• Cryotherapy applied to the break before or during buckling induces a chorioretinal adhesion to seal the break. Subretinal fluid is typically reabsorbed spontaneously without drainage.
• Preferred in young phakic patients and inferior detachments where pneumatic retinopexy is not suitable. Preserves the natural lens and avoids intraocular surgery risks.

3. Pars Plana Vitrectomy (PPV)

• Involves removal of the vitreous gel via small-gauge (23G, 25G, or 27G) transconjunctival trocars, relief of vitreous traction, direct visualisation and treatment of all breaks, and internal tamponade with gas (SF6 15–20% for 4–6 weeks, C3F8 12–14% for 6–10 weeks) or silicone oil (for complex cases, GRT, PVR).
• The PIVOT trial (UK) demonstrated non-inferiority of PPV compared to scleral buckling for primary RRD in pseudophakic eyes, supporting PPV as the preferred approach in this population.
• PPV is the procedure of choice for TRD (diabetic), GRT, posterior breaks, PVR, and cases with opaque media (vitreous haemorrhage).

Prophylaxis for Fellow Eye

• Laser retinopexy around subclinical retinal breaks, lattice degeneration with syneresis, or symptomatic horseshoe tears in the fellow eye reduces, but does not eliminate, the risk of RRD.

Retinal detachment surgery has high success rates when performed promptly by experienced vitreoretinal surgeons:

• Anatomical success: Primary reattachment rates exceed 85–95% for RRD repair with modern surgical techniques. PPV achieves anatomical reattachment in >90% of straightforward RRD cases with a single procedure.
• Visual recovery (macula-on): The majority of patients with macula-on RRD who undergo prompt surgery achieve visual acuity of 20/40 or better. Post-operative visual acuity in macula-on cases is typically excellent (>90% achieving 6/12 or better) when surgery occurs within 24 hours.
• Visual recovery (macula-off): Visual recovery is less predictable and depends on the duration of macular detachment. Eyes with <7 days of macular detachment have meaningfully better visual prognosis than those with longer durations. OCT outer retinal layer integrity (ellipsoid zone) is a strong predictor of visual outcome.
• Minimally invasive PPV: The 25G and 27G transconjunctival sutureless vitrectomy systems enable faster surgery, reduced post-operative inflammation, and quicker recovery compared to older 20G systems, with equivalent efficacy.
• PIVOT trial validation: This landmark UK trial confirmed that patients undergoing PPV for pseudophakic RRD achieved equivalent anatomical and functional outcomes to those undergoing scleral buckling, with some centres demonstrating faster visual rehabilitation with PPV.

Retinal detachment surgery is generally safe but carries procedure-specific risks that patients must be counselled about:

Intraoperative Risks (PPV and SB)

• Inadvertent retinal breaks during vitrectomy; repaired intraoperatively with laser
• Suprachoroidal haemorrhage (rare but serious, more common in scleral buckling)
• Lens damage during vitrectomy in phakic patients

Post-Operative Complications

• Proliferative vitreoretinopathy (PVR): The most common cause of surgical failure (5–10% of cases). Contractile membranes form on the retinal surface, pulling it into re-detachment. Requires revision PPV with membrane peeling and silicone oil tamponade.
• Cataract formation: Occurs in virtually all phakic patients within 1–2 years following PPV, particularly with gas or oil tamponade. Combined cataract and vitrectomy surgery (“phacovitrectomy”) is increasingly performed to avoid a second operation.
• Elevated intraocular pressure (IOP): Gas over-expansion or silicone oil migration into the anterior chamber can raise IOP, requiring medical management.
• Diplopia: Occurs following scleral buckling due to extraocular muscle imbalance from the buckle; usually resolves but may require prism or strabismus surgery.
• Hypotony: Low IOP from ciliary body damage or persistent subretinal fluid leakage.
• Endophthalmitis: Rare but serious post-operative infection; incidence approximately 0.05–0.1%.

Aviation Restriction — Critical Safety Notice:

• Patients with intraocular gas (SF6 or C3F8) must not fly or travel to high altitude until the gas has completely absorbed. The reduction in cabin pressure causes gas expansion that can dramatically raise IOP and cause central retinal artery occlusion, resulting in blindness. Patients should carry a warning card for at least 6 weeks following gas surgery.

Structured post-operative follow-up is essential for monitoring retinal reattachment, managing complications, and ensuring visual rehabilitation:

Positioning:

• Gas tamponade requires strict head positioning to maintain the bubble over the retinal break. For superior breaks (common), face-up (supine) positioning is required for 1–5 days. Inferior breaks require face-down positioning. Patients are instructed in correct positioning using a head support pillow or mirror system.
• Silicone oil does not require positioning as it provides a more stable, gravity-independent tamponade.

Post-Operative Visit Schedule:

• Day 1: IOP check (critical to exclude gas-related hypertension or hypotony), assessment of gas fill, and fundal view
• Week 1–2: Assess retinal reattachment on indirect ophthalmoscopy; check wound integrity
• Month 1: Assess macula status, visual acuity, and residual subretinal fluid on OCT
• Month 3 and 6: Visual acuity refraction (significant refractive changes common post-SB due to altered axial length); screen for fellow eye breaks

Silicone Oil Removal:

• Silicone oil is a temporary tamponade agent; it requires surgical removal (under local or general anaesthesia) at 3–6 months to prevent long-term complications including emulsification, cataract, and IOP elevation.

Fellow Eye Surveillance:

• The risk of RRD in the fellow eye is approximately 10–15%. Annual dilated fundus examination and prompt evaluation of new symptoms (floaters, flashes) in the fellow eye are essential.

The cost of retinal detachment repair varies considerably by procedure type, setting, and healthcare system:

• Pneumatic retinopexy: The least expensive option, performed in an outpatient clinic setting without operating room costs. Total cost (including cryotherapy/laser and gas) is USD 500–2,000 in the USA. The higher re-operation rate in non-ideal candidates can offset initial savings.
• Scleral buckling: Requires an operating room, local or general anaesthesia, and silicone hardware. Typical cost in the USA is USD 5,000–15,000 (facility + surgeon fee). Implant costs add USD 200–500. Cost-effective for young phakic patients who avoid PPV risks and subsequent cataract surgery.
• Pars plana vitrectomy (PPV): Operating room costs, disposable vitrectomy packs (USD 400–800), gas or silicone oil (USD 300–600 for oil), and surgeon fee typically sum to USD 8,000–20,000 in the USA. 25G and 27G systems are comparable in cost to 23G.
• Silicone oil removal: A second operating room procedure at USD 3,000–8,000 adds to the total cost of complex RRD management.
• Medical tourism: Vitreoretinal surgery by fellowship-trained surgeons in India, Thailand, Turkey, and Mexico is available at USD 1,500–5,000 per procedure, representing savings of 60–80% versus US/UK pricing. Centres in Chennai, Mumbai, Bangkok, and Istanbul have internationally accredited vitreoretinal units with high-volume surgical experience.

While surgery is the only definitive treatment for RRD and TRD, several preventive and adjunctive strategies are relevant:

• Laser retinopexy (prophylaxis): Demarcation laser photocoagulation applied around subclinical or non-progressive retinal breaks and lattice degeneration creates a chorioretinal adhesion that reduces, but does not eliminate, the risk of progression to RRD. The decision to treat asymptomatic breaks is individualised based on lesion type, extent, fellow eye status, and vitreous status.
• Observation for exudative RD: Serous RD caused by uveitis or CSC (central serous chorioretinopathy) may resolve with treatment of the underlying condition without surgical retinal intervention. Small peripheral exudative detachments associated with systemic hypertension often resolve with blood pressure control.
• Cryotherapy: Applied to retinal breaks at the time of scleral buckling or as an isolated office procedure for small peripheral tears. Induces inflammatory adhesion between the retina and RPE over 1–2 weeks.
• Watchful waiting is not appropriate for established RRD as delaying surgery invariably allows the detachment to extend toward the macula, worsening prognosis. No pharmacological treatments can reattach the retina.
• Intraocular gas alternatives: Silicone oil is used when gas is contraindicated (e.g., patients who must fly for medical reasons, inability to position, severe PVR). Its permanent tamponading effect makes it suitable for complex cases at high risk of re-detachment.